The Impact of Metabolic Syndrome on 30-Day Complications Following Total Joint Arthroplasty

Edelstein, Adam I.; Lovecchio, Francis; Delagrammaticas, Dimitri E.; Fitz, David W.; Hardt, Kevin D.; Manning, David W.

doi:10.1016/j.arth.2016.08.007

Cited by 42 publications

(22 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…51 Regarding medical comorbidities, risk factors for complications of arthroplasty include metabolic syndrome, chronic obstructive pulmonary disease, multiple sclerosis, and Parkinson's disease. [52][53][54][55] Obese patients with a body mass index (BMI) > 35 were shown to have a higher incidence of infection and wound complications. 56,57 Smoking is also associated with a greater risk of infection.…”

Section: Neoplasmmentioning

confidence: 99%

Imaging of Hip Arthroplasties: Normal Findings and Hardware Complications

Deshmukh

Omar

2019

Semin Musculoskelet Radiol

View full text Add to dashboard Cite

Hip arthroplasty is a common and largely successful surgical procedure, often used for the treatment of advanced osteoarthritis. Imaging plays a key role in routine postoperative imaging surveillance as well as the evaluation of post-arthroplasty pain. Radiographs are the first-line imaging modality and may be followed by computed tomography (CT), ultrasound, and/or magnetic resonance imaging (MRI). Recent advancements in imaging techniques allow for metal artifact reduction on CT and MRI. A variety of complications can arise in the setting of arthroplasty: mechanical loosening, component wear-induced synovitis and osteolysis, adverse local tissue reaction, infection, periprosthetic fracture, implant dislocation and/or component displacement, tendinopathy, and neurovascular injury. This article reviews normal and abnormal imaging findings of hip arthroplasty.

show abstract

Section: Neoplasmmentioning

confidence: 99%

Imaging of Hip Arthroplasties: Normal Findings and Hardware Complications

Deshmukh

Omar

2019

Semin Musculoskelet Radiol

View full text Add to dashboard Cite

show abstract

“…Metabolic syndrome (MetS) (dyslipidemia, hypertension, abnormal fasting glucose, and visceral obesity) was found to be an independent risk factor for Centers for Medicare & Medicaid Services (CMS)-reportable complications, wound complications, and readmission following total joint arthroplasty (TJA) 27 . The group with MetS and a BMI of >40 kg/m 2 was noted to have a significantly higher risk compared with lower BMI groups.…”

Section: Patient Factors In Relation To Outcomes Medical Comorbiditiesmentioning

confidence: 99%

What’s New in Hip Replacement

Glassman

2018

The Journal of Bone and Joint Surgery

View full text Add to dashboard Cite

show abstract

“…Although surgical complications are common in the daily practice of surgeons, they are considered serious issues related to surgery [1], which exacerbate the suffering of patients and lead to lengthy hospital stays and higher medical expenses. In recent years, the impact of metabolic syndrome on different surgical operations has gained significant attention [2][3][4][5][6][7]. Several risk factors that could affect convalescence, including age, gender, disease history, physical status of the patient, anesthesia, blood loss, and wound condition, have been reported.…”

Section: Introductionmentioning

confidence: 99%

Impact of the Agents Treated for Metabolic Syndrome on Surgical Complications

Hsu¹

2019

OAJUN

View full text Add to dashboard Cite

Background: The impact of metabolic syndrome (MS) on different surgical operations has gained significant attention recently. However, to date, it is unclear whether the medications used to treat MS can have an effect on surgical complications. Objectives: In this study, we aimed to investigate the effects of therapeutic agents used for the treatment of metabolic syndrome on surgical complications. Methods: We performed a retrospective case-control study based on chart reviews of 2624 surgical patients at our hospital in 2016. Data regarding surgical complications obtained from the hospital records were analyzed using binary logistic regression. The independent variables were angiotensin-converting-enzyme inhibitor, angiotensin receptor blocker (ARB), dihydropyridine calcium-channel blockers (DCCB), diuretics, potassium-sparing diuretics, nondihydropyridine calcium-channel blockers (NDCCB), dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonists (GLP1 agonists), nonselective beta-blockers, selective beta-blockers, peripheral vasodilators, alpha-glucosidase inhibitors, insulin, metformin, sulfonylureas, thiazolidinediones, bile acid sequestrants, fibrates, and statins. The dependent variable was surgical complications. Among the surgical patients included in the study, 328 (12.5%) had a history of metabolic syndrome. Results: In diseases with the same severity score [≥ ASA 3(American Society of Anesthesiologists)], diuretics, NDCCB, DCCB, insulin, GLP1 agonists, and selective beta-blockers had a significant influence in univariate logistic regression. However, multivariate logistic regression using control variables showed that only diuretic use was statistically significant (odds ratio 1.968, 95% confidence interval 1.141-3.394, p = 0.015).

show abstract

The Impact of Metabolic Syndrome on 30-Day Complications Following Total Joint Arthroplasty

Cited by 42 publications

References 31 publications

Imaging of Hip Arthroplasties: Normal Findings and Hardware Complications

Imaging of Hip Arthroplasties: Normal Findings and Hardware Complications

What’s New in Hip Replacement

Impact of the Agents Treated for Metabolic Syndrome on Surgical Complications

Contact Info

Product

Resources

About